Key result
Lactate may promote hypoglycemia-associated autonomic failure by increasing hypothalamic GABA and suppressing glucose counterregulation.
Discusses the mechanism of hypoglycemia-associated autonomic failure in diabetes, highlighting the interplay of therapeutic insulin excess and compromised physiological defenses.
Answers are grounded in this paper and cite their sources.
Highlights potential therapeutic targets to restore counterregulation in diabetes; leaves open whether lactate modulation alters clinical hypoglycemia risk.
Iatrogenic hypoglycemia is a problem for many peo-ple with diabetes (1). It causes recurrent morbidityin most people with type 1 diabetes and many withadvanced type 2 diabetes and is sometimes fatal. It generally precludes maintenance of euglycemia over a lifetime of diabetes and therefore full realization of the benefits of glycemic control. It impairs defenses against subsequent falling plasma glucose concentrations and causes a vicious cycle of recurrent hypoglycemia. Hypoglycemia in diabetes is typically the result of the interplay of therapeutic insulin excess—caused by treat-ment with insulin, a sulfonylurea, or a glinide—and com-promised physiological and behavioral defenses against falling plasma glucose concentrations (1,2). Compromised physiological defenses include loss of the normal decrease in b-cell insulin secretion and increase in a-cell glucagon secretion and attenuation of the normal increase in adreno-medullary epinephrine secretion during hypoglycemia. The
No takes yet. Share an insight, caveat, or question.
Arbeláez et al. (2013) conducted an editorial in Hypoglycemia-Associated Autonomic Failure (HAAF) in Diabetes. Lactate was evaluated. Lactate may act as a signaling molecule in the ventromedial hypothalamus to increase GABA levels and suppress glucose counterregulation, contributing to hypoglycemia-associated autonomic failure.
Synapse has enriched 10 related papers. Consider them for comparative context: